<DOC>
	<DOCNO>NCT00321438</DOCNO>
	<brief_summary>The purpose study measure viral tropism time subject X4-tropic non-phenotypeable virus receive standard care therapy . This observational study . No investigational treatment administer study .</brief_summary>
	<brief_title>Observational Study HIV-Infected Subjects With X4-Tropic Non-Phenotypeable Virus</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIVinfected . Screening viral load least 5000copies/mL . X4tropic nonphenotypeable virus screening . Total prior antiretroviral experience least 3 month document resistance least one drug follow class : NRTI , NNRTI , PI , stable antiretroviral regimen ( antiretroviral treatment ) least 4 week screen . Able receive ritonavirboosted protease inhibitor treatment study . Women childbearing potential must use specific form contraception . Exclusion criterion : R5tropic R5/X4tropic virus screening , change antiretroviral therapy 4 week prior screen Day 1 observational study . Pregnant breastfeed woman . Significant ECG abnormality significant history active pancreatitis , hepatitis , opportunistic infection , cancer , severe illness . Current use certain medication may exclude participation study . Additional qualify criterion laboratory test requirement determine study physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>HIV-1</keyword>
	<keyword>GW873140</keyword>
	<keyword>CCR5 antagonist</keyword>
	<keyword>experienced</keyword>
	<keyword>treatment experience</keyword>
</DOC>